CureVac N.V. provided its financial results for the first quarter of 2025 along with business updates. The press release includes forward-looking statements about the company’s vaccine and treatment candidates, strategies, financing plans, cash runway expectations, regulatory approval, growth opportunities, and market growth. These statements are based on current beliefs and assumptions but are subject to various risks and uncertainties such as economic conditions, regulatory challenges, competition, and the impact of the COVID-19 pandemic. Readers are advised not to rely excessively on these statements due to the unpredictable nature of the factors influencing the company’s actual performance. The company emphasizes the importance of considering the risks outlined in its annual report and other SEC filings when evaluating the forward-looking statements provided.
Read more from finance.yahoo.com
